Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Petar Antonov Vazharov | CEO & Director | 34.72M | -- | -- |
| Ms. Eeling Chan | Chief Financial Officer | 5.19M | -- | -- |
| Mr. Vamsi Kiran Kosaraju | Chief Operations Officer | -- | -- | -- |
| Ms. Gwen Hsieh | Chief Information Officer | -- | -- | -- |
| Ms. Yu-Ying Yang | Associate Director of Co-Operate Communication | -- | -- | -- |
| Boon Chong Tan | Deputy General Manager | -- | -- | -- |
| Mr. Edin Buljubasic | Vice President | -- | -- | -- |
| Yingming Yue | Vice President | -- | -- | -- |
| Valerie Lau | Chief Commercial Officer-APAC | -- | -- | -- |
| Mr. Manish Chawla | Vice President of Research and Development | -- | -- | -- |
Lotus Pharmaceutical Co., Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. The company also provides over-the-counter products. In addition, it engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. The company has strategic partnership with NRX Pharmaceuticals. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.
Corporate Governance
Upcoming Events
May 9, 2025 at 10:59 AM UTC - May 13, 2025 at 12:00 PM UTC
Lotus Pharmaceutical Co., Ltd. Earnings Date
Recent Events
August 5, 2024 at 12:00 AM UTC
Ex-Dividend Date